Abstract
Alzheimer’s disease (AD) is the most common form of dementia that affects more than 40 million people around the world. The incidence is expected to rapidly increase due to the lack of any effective treatment. In previous work we synthesized a family of five ionophoric polyphenols (compounds 1–5) that targeted important aspects related to AD, such as the toxic aggregation of amyloid-β peptides, the production of reactive oxygen species, or the excessive presence of Cu2+ ions. Here, in order to gain insights into their potential therapeutic value, we have tested the ability of compounds 1–5 to cross the blood–brain barrier (BBB), to interact with human serum albumin (HSA) and Calf Thymus (ct) DNA, and to inhibit acetylcholinesterase (AChE). We performed BBB permeability and efflux mechanisms studies by means of the in vitro parallel artificial membrane permeability assay (PAMPA-BBB) and several in silico methods, while fluorescence, UV–visible, and circular dichroism spectroscopies were used to determine their ability to interact with HSA and ctDNA. Our results show that all five ionophoric polyphenols can effectively cross the BBB, and can form adducts with both HSA and ctDNA through one binding site and with association constants ranging from 104 to 106 M−1, while still maintaining levels of unbound drug to protein within therapeutic range. Docking and molecular dynamics simulations show that the ionophoric polyphenols preferably bind the hydrophobic cavities of the subdomain IIA of HSA, as many other pharmaceuticals do, with predicted affinities that correlate well with experimental results obtained by spectroscopic techniques. In addition, structurally related compounds 1, 2, and 4 were found to be moderate in vitro AChE inhibitors by interacting with several residues of the active site of the enzyme, as revealed by docking and molecular dynamics simulations. Overall, our results suggest that HSA could be an efficient transport mechanism of the compounds in the bloodstream until reaching the brain, where they could effectively cross the BBB and exert their anti-AD activity, including AChE inhibition. DNA interactions similar to natural resveratrol could in part explain the previously reported nontoxic behavior of the compounds.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahmed-Ouameur A, Marty R, Tajmir-Riahi HA (2005) Human serum albumin complexes with chlorophyll and chlorophyllin. Biopolymers 77(3):129–136. https://doi.org/10.1002/bip.20173
Alzheimer’s Association (2020) Facts and figures. https://www.alz.org/alzheimers-dementia/facts-figures. Accessed 7 Aug 2020
Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NME, Romano DM, Hartshorn MA, Tanzi R, Bush AI (1998) Dramatic aggregation of Alzheimer Ab by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 273(21):12817–12826. https://doi.org/10.1074/jbc.273.21.12817
Bajda M, Guzior N, Ignasik M, Malawska B (2011) Multi-target-directed ligands in Alzheimer’s disease. Curr Med Chem 18(32):4949–4975. https://doi.org/10.2174/092986711797535245
Birdsall B, King RW, Wheeler MR, Lewis Jr CA, Goode SR, Dunlap RB, Roberts GC (1983) Correction for light absorption in fluorescence studies of protei-ligand interactions. Anal Biochem 132(2):353–361. https://doi.org/10.1016/0003-2697(83)90020-9
Bourassa P, Kanakis CD, Tarantilis P, Pollissiou MG, Tajmir-Riahi HA (2010) Resveratrol, genistein, and curcumin bind bovine serum albumin. J Phys Chem B 114(9):3348–3354. https://doi.org/10.1021/jp9115996
Case DA, Cheatham TE, Darden T, Gohlke H, Luo R, Merz KM, Onufriev A, Simmerling C, Wang B, Woods RJ (2005) The Amber biomolecular simulation programs. J Comput Chem 26(16):1668–1688. https://doi.org/10.1002/jcc.20290
Colovic MB, Krstic D, Lazarevic-Pasti TD, Bondzic AM, Vasic VM (2013) Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol 11(3):315–335. https://doi.org/10.2174/1570159X11311030006
Dargo G, Bajusz D, Simon K, Muller J, Balogh G (2020) Human serum albumin binding in a vial: a novel UV-pH titration method to assist drug design. J Med Chem 63: 1763–1774. https://doi.org/10.1021/acs.jmedchem.0c00046
Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet 308(8000):1403. https://doi.org/10.1016/S0140-6736(76)91936-X
Di L, Kerns EH, Fan K, McConell O, Carter GT (2003) High throughput artificial membrane permeability assay fro blood-brain barrier. Eur J Med Chem 38(3):223–232. https://doi.org/10.1016/s0223-5234(03)00012-6
Divsalar A, Bagheri MJ, Saboury AA, Mansoori-Torhizi H, Amani M (2009) Investigation on the interaction of newly designed anticancer Pd(II) complexes with different aliphatic tails and human serum albumin. J Phys Chem B 113(42):14035–14042. https://doi.org/10.1021/jp904822n
Do H, Li H, Chreifi G, Poulos TL, Silverman RB (2019) Optimization of blood-brain barrier permeability with potent and selective human neuronal nitric oxide synthase inhibitors having a 2-aminopyridine scaffold. J Med Chem 62:2690–2707. https://doi.org/10.1021/acs.jmedchem.8b02032
Dvir H, Silman I, Harel M, Rosenberry TL, Sussman JL (2010) Acetylcholinesterase: from 3D structure to function. Chem Biol Interact 187(1–3):10–22. https://doi.org/10.1016/j.cbi.2010.01.042
Fasano M, Curry S, Terreno E, Galliano M, Fanali G, Narciso P, Notari S, Ascenzi P (2005) The extraordinary ligand binding properties of human serum albumin. IUBMB Life 57(12):787–796. https://doi.org/10.1080/15216540500404093
Froehlich E, Mandeville JS, Jennings CJ, Sedaghat-Herati R, Tajmir-Riahi A (2009) Dendrimers bind human serum albumin. J Phys Chem B 113:6986–6993. https://doi.org/10.1021/jp9011119
Greenblatt HM, Kryger G, Lewis T, Silman I, Sussman JL (1999) Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution. FEBS Lett 463(3):321–326. https://doi.org/10.1016/s0014-5793(99)01637-3
Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E, Hutchison GR (2012) Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminformatics 4(1):17. https://doi.org/10.1186/1758-2946-4-17
Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth C, Axelsen PH, Silman I, Sussman JL (1993) Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. PNAS 90(19):9031–9035. https://doi.org/10.1073/pnas.90.19.9031
Hollosy F, Valko K, Hersey A, Nunhuck S, Keri G, Bevan C (2006) Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilized artificial membrane partitioning. J Med Chem 49:6958–6971. https://doi.org/10.1021/jm050957i
Hu J, Pan T, An B, Li Z, Li X, Huang L (2019) Synthesis and evaluation of clioquinol-rolipram/reflumilast hybrids as multitarget-directed ligands for the treatment of Alzheimer’s disease. Eur J med Chem 163:512–526. https://doi.org/10.1016/j.ejmech.2018.12.013
Hu YJ, Liu Y, Wang JB, Xiao XH, Qu SS (2004) Study of the interaction between monoammonium glycyrrhizinate and bovine serum albumin. J Pharm Biomed Anal 36(4):915–919. https://doi.org/10.1016/j.jpba.2004.08.021
Janjua NK, Siddiqa A, Yaqub A, Sabahat S, Qureshi R, Haque S (2009) Spectrophotometric analysis of flavonoid-DNA binding interactions at physiological conditions. Spectrochim Acta A 74:1135–1137. https://doi.org/10.1016/j.saa.2009.09.022
Johnson G, Moore SW (2006) The peripheral anionic site of acetylcholinesterase: structure, functions and potential role in rational drug design. Curr Pharm Des 12(2):217–225. https://doi.org/10.2174/138161206775193127
Kalb A, von Haefen C, Sifringer M, Tegethoff A, Paeschke N, Kostova M, Feldheiser A, Spies CD (2013) Acetylcholinesterase inhibitors reduce neuroinflammation and degeneration in the cortex and hippocampus of a surgery stress rat model. PLoS ONE 8(5):e62679. https://doi.org/10.1371/journal.pone.0062679
Kandagal PB, Ashoka S, Seetharamappa SA, Shaikh SMT, Jadegoud Y, Ijare OB (2006) Study of the interaction of an anticancer drug with human and bovine serum albumin: spectroscopic approach. J Pharm Biomed Anal 41(2):393–399. https://doi.org/10.1016/j.jpba.2005.11.037
Kratochwil NA, Huber W, Muller F, Kansy M, Gerber PR (2002) Predicting plasma protein binding of drugs: a new approach. Biochem Pharm 64:1355–1374. https://doi.org/10.1016/s0006-2952(02)01074-2
Kung HF, Choi SR, Qu W, Zhang W, Skovronsky D (2010) 18F stilbenes and styrylpyridines for PET imaging of Ab plaques in Alzheimer’s disease: a miniperspective. J Med Chem 53(3):933–941. https://doi.org/10.1021/jm901039z
Lakowicz J (2006) Principles of fluorescence spectroscopy, 3rd edn. Springer, U.S. p 262
Levatic J, Curak J, Kralj M, Smuc T, Osmak M, Supek F (2013) Accurate models for P-gp drug recognition induced from a cancer cell line cytotoxicity screen. J Med Chem 56:5691–5708. https://doi.org/10.1021/jm400328s
Li M, Hagerman AE (2014) Role of the flavan-3-Ol and galloyl moieties in the interaction of (−)-epigallocatechin gallate with serum albumin. J Agric Food Chem 62(17):3768–3775. https://doi.org/10.1021/jf500246m
Lu Y, Lv J, Zhang G, Wang G, Liu Q (2010) Interaction of an anthracycline disaccharide with ctDNA: investigation by spectroscopic technique and modeling studies. Spectrochim Acta A 75(5):1511–1515. https://doi.org/10.1016/j.saa.2010.02.008
Lu Z, Zhang Y, Liu H, Yuan J, Zheng Z, Zou G (2007) Transport of a cancer chemopreventive polyphenol, resveratrol: interaction with serum albumin and hemoglobin. J Fluoresc 17(5):580–587. https://doi.org/10.1007/s10895-007-0220-2
Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C (2015) Ff14SB: improving the accuracy of protein side chain and backbone parameters from Ff99SB. J Chem Theory Comput 11(8):3696–3713. https://doi.org/10.1021/acs.jctc.5b00255
Martinez A, Alcendor R, Rahman T, Podgorny M, Sanogo I, McCurdy R (2016) Ionophoric polyphenols selectively bind Cu2+, display potent antioxidant and anti-amyloidogenic properties, and are non-toxic toward Tetrahymena thermophila. Bioorg Med Chem 24:3657–3670. https://doi.org/10.1016/j.bmc.2016.06.012
Maruthamuthu M, Selvakumar G (1995) Selective quenching of tryptophanyl fluorescence in bovine serum albumin by the iodide ion. Proc Indian Acad Sci (Chem Sci) 107:79–86. https://doi.org/10.1007/BF02841442
Miller BR, McGee TD, Swails JM, Homeyer N, Gohlke H, Roitberg AE (2012) MMPBSA.Py: an efficient program for end-state free energy calculations. J Chem Theory Comput 8(9):3314–3321. https://doi.org/10.1021/ct300418h
Nair MS (2015) Spectroscopic study on the interaction of resveratrol and pterostilbene with human serum albumin. J Photochem Photobiol B 149:58–67. https://doi.org/10.1016/j.jphotobiol.2015.05.001
National Institute on Aging (2016) Alzheimer’s disease cooperative Study. https://clinicaltrials.gov/ct2/show/NCT01504854. Accessed 7 Aug 2020
Ritchie CW, Bush A, Mackinnon A (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Ab amyloid deposition and toxicity in Alzheimer disease. Arch Neurol 60(12):1685–1691. https://doi.org/10.1001/archneur.60.12.1685
Rodda J, Carter J (2012) Cholinesterase inhibitors and memantine for symptomatic treatment of dementia. BMJ 344:e2986. https://doi.org/10.1136/bmj.e2986
Samaroo D, Zahran M, Wills AC, Guevara J, Tatonetti A (2019) In vitro interaction and computational studies of glycosylated photosensitizers with plasma proteins. J Porphyr Phthalocyanines 23(04n05):437–452. https://doi.org/10.1142/S1088424619500275
Samworth CM, Esposti MD, Lenaz G (1988) quenching of the intrinsic tryptophan fluorescence of mitochondrial ubiquinol cytochrome-c reductase by the binding of ubiquinone. Eur J Biochem 171(1-2):81–86. https://doi.org/10.1111/j.1432-1033.1988.tb13761.x
Sayed M, Krishnamurthy B, Pal H (2016) Unraveling multiple binding modes of acridine orange to DNA using a multispectroscopic approach. Phys Chem Chem Phys 18:24642–24653. https://doi.org/10.1039/C6CP03716J
Singha Roy A, Ghosh KS, Dasgupta S (2013) An investigation into the altered binding mode of green tea polyphenols with human serum albumin on complexation with copper. J Biomol Struct Dyn 31(10):1191–1206. https://doi.org/10.1080/07391102.2012.729158
Soukpoe-Kossi CNN, St-Lois C, Beauregard M, Subirade M, Carpentier R, Hotchandani S, Tajmir-Riahi HA (2006) Resveratrol binding to human serum albumin. J Biomol Struc Dyn 24(3):277–283. https://doi.org/10.1080/07391102.2006.10507120
Stern O, Volmer M (1919) Uber die abklingzeit der fluoreszenz. Phys Z 20:103–188
Stoddard SV, Hamann MT, Wadkins RM (2014) Insights and ideas garnered from marine metabolites for development of dual-function acetylcholinesterase and amyloid-β aggregation inhibitors. Mar Drugs 12(4):2114–2131. https://doi.org/10.3390/md12042114
Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K (1999) Crystal structure of human serum albumin at 12.5 A resolution. Protein Eng 12(6):436–446. https://doi.org/10.1093/protein/12.6.439
Thiratmatrakul S, Yenjai C, Waiwut P, Vajragupta O, Reubroycharoen P, Tohda M, Boonyarat C (2014) Synthesis, biological evaluation and molecular modeling study of novel tracrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer’s disease. Eur J Med Chem 75:21–30. https://doi.org/10.1016/j.ejmech.2014.01.020
Van Asperen J, Mayer U, van Tellingen Beijnen JH (1997) The functional role of p-glycoprotein in the blood brain barrier. J Pharm Sci 86(8):881–884. https://doi.org/10.1021/js9701364
Watanabe R, Esaki T, Kawashima H, Natsume-Kitatani Y, Nagao C, Ohashi R, Mizuguchi K (2018) Predicting fraction unbound in human plasma from chemical structure: improved accuracy in the low value ranges. Mol Pharm 15(11):5302–5311. https://doi.org/10.1021/acs.molpharmaceut.8b00785
Whitmore L, Wallace BA (2004) DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nuc Ac Res 32(2):W668–W673. https://doi.org/10.1093/nar/gkh371
Whitmore L, Wallace BA (2008) Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases. Biopolymers 89(5):392–400. https://doi.org/10.1002/bip.20853
Wieckowska A, Kolaczkowski M, Bucki A, Godyn J, Marcinkowska M, Wieckowski K, Zareba P, Siwek A, Kazek G, Gluch-Lutwin M, Mierzejewski P, Bienkowski P, Sienkiewicz Jarosz H, Knez D, Wichur T, Gobec S, Malawska B (2016) Novel multi-target-directed ligands for Alzheimer’s disease: combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation. Eur J Med Chem 124:63–81. https://doi.org/10.1016/j.ejmech.2016.08.016
Yates CM, Butterworth J, Tennant MC, Gordon A (1990) Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type an other dementias. J Neurochem 55(5):1624–1630. https://doi.org/10.1111/j.1471-4159.1990.tb04948.x
Zhang S, Sun X, Jing Z, Qu F (2011) Spectroscopic analysis on the resveratrol-DNA binding interactions at physiological pH. Spectrochim. Acta A 82(1):213–216. https://doi.org/10.1016/j.saa.2011.07.037
Zhou SF (2008) Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 38:802–832. https://doi.org/10.1080/00498250701867889
Zhou Y, Wang S, Zhang Y (2010) Catalytic reaction mechanism of acetylcholinesterase determined by Born-Oppenheimer ab initio QM/MM molecular dynamics simulations. J Phys Chem B 114(26):8817–8825. https://doi.org/10.1021/jp104258d
Acknowledgements
Financial support from NYC College of Technology (CUNY), PSC-CUNY grant #62067-00-50, and Emerging Scholar program is gratefully acknowledged. We are also grateful to the Center for Theoretical Physics of NYC College of Technology for providing computational resources.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Martínez, A., Zahran, M., Gomez, M. et al. Ionophoric polyphenols are permeable to the blood–brain barrier, interact with human serum albumin and Calf Thymus DNA, and inhibit AChE enzymatic activity. Med Chem Res 29, 1956–1975 (2020). https://doi.org/10.1007/s00044-020-02615-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-020-02615-3